measuregroup/AID114873

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103188413_AID114873_PMID2724297_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103164546_AID114873_PMID2724297_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103177753_AID114873_PMID2724297_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103188479_AID114873_PMID2724297_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103188445_AID114873_PMID2724297_VALUE4
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10090
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Effective dose required to inhibit ataxia after intraperitoneal administration in experiment 1
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103188479 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103188445 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103164546 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103188413 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103177753
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID114873

Total number of triples: 15.